Effect of different infusion methods of dexmedetomidine on the incidence of rebound pain after shoulder arthroscopic surgery in patients with catastrophic preoperative pain

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200067064

Enrollment

Unknown

Registered

2022-12-26

Start date

2022-12-12

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shoulder sleeve damage

Interventions

Experimental group:Dextrmedetomidine as an Adjuvant of Local Anesthesia for Nerve Block

control group:Dextrmedetomidine intravenous injection

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The patients who need shoulder surgery at a selected time are 18-65 years old, and ASA (American Association of Anesthesiologists Classification) I-II. 2. Pain Catastrophe Scale score>26 and Neuropathic Pain Assessment Scale DN4<4. 3. Day surgery patients discharged within the second day of surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with PCS score = 26; 2. Patients with DN4 = 4 points; 3. Patients who refused to participate in the experiment, patients who were allergic to various drugs in the experiment, patients with chronic peripheral neuropathy, patients with puncture point infection, and patients who refused or could not understand the questionnaire.

Design outcomes

Primary

Measure	Time frame
Occurrence rate of rebound pain;	—

Secondary

Measure	Time frame
Postoperative NRS score;Athens Insomnia Scale;Sensory recovery time;Motion recovery time;	—

Countries

China

Contacts

Public ContactHUAN XIANG

Xuzhou Central Hospital

120895745@QQ.COM+86 18952111208

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026